Subjective cognitive decline: The first clinical manifestation of alzheimer’s disease?

98Citations
Citations of this article
193Readers
Mendeley users who have this article in their library.

Abstract

Background: Mild cognitive impairment is considered as the first clinical manifestation of Alzheimer’s disease (AD), when the individual exhibits below performance on standardized neuropsychological tests. However, some subjects before having a lower performance on cognitive assessments already have a subjective memory complaint. Objective: A review about subjective cognitive decline, the association with AD biomarkers and risk of conversion to dementia. Methods: We performed a comprehensive non-systematic review on PubMed. The keywords used in the search were terms related to subjective cognitive decline. Results: Subjective cognitive decline is characterized by self-experience of deterioration in cognitive performance not detected objectively through formal neuropsychological testing. However, various terms and definitions have been used in the literature and the lack of a widely accepted concept hampers comparison of studies. Epidemiological data have shown that individuals with subjective cognitive decline are at increased risk of progression to AD dementia. In addition, there is evidence that this group has a higher prevalence of positive biomarkers for amyloidosis and neurodegeneration. However, Alzheimer’s disease is not the only cause of subjective cognitive decline and various other conditions can be associated with subjective memory complaints, such as psychiatric disorders or normal aging. The features suggestive of a neurodegenerative disorder are: onset of decline within the last five years, age at onset above 60 years, associated concerns about decline and confirmation by an informant. Conclusion: These findings support the idea that subjective cognitive complaints may be an early clinical marker that precedes mild cognitive impairment due to Alzheimer’s disease.

References Powered by Scopus

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

11529Citations
N/AReaders
Get full text

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5502Citations
N/AReaders
Get full text

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

3674Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Subjective Cognitive Decline and Related Cognitive Deficits

56Citations
N/AReaders
Get full text

Role of milk and dairy intake in cognitive function in older adults: A systematic review and meta-analysis

48Citations
N/AReaders
Get full text

Chronic kidney disease, physical activity and cognitive function in older adults - results from the National Health and Nutrition Examination Survey (2011-2014)

35Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Neto, A. S., & Nitrini, R. (2016). Subjective cognitive decline: The first clinical manifestation of alzheimer’s disease? Dementia e Neuropsychologia, 10(3), 170–177. https://doi.org/10.1590/s1980-5764-2016dn1003002

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 79

76%

Researcher 15

14%

Professor / Associate Prof. 10

10%

Readers' Discipline

Tooltip

Psychology 33

36%

Medicine and Dentistry 27

29%

Neuroscience 22

24%

Nursing and Health Professions 10

11%

Save time finding and organizing research with Mendeley

Sign up for free